HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Type II Lattice Corneal Dystrophy

Also Known As:
Lattice Corneal Dystrophy, Type II; Corneal Dystrophy, Lattice Type II; Familial Amyloid Polyneuropathy Type Iv; Familial Amyloidosis, Finnish Type; Gelsolin-Related Amyloidosis; Kymenlaakso Syndrome; Lattice Corneal Dystrophy Type Ii; Lattice Corneal Dystrophy, Gelsolin Type
Networked: 39 relevant articles (0 outcomes, 4 trials/studies)

Disease Context: Research Results

Related Diseases

1. Amyloidosis
2. Amyloid Plaque
3. Familial Mediterranean Fever (Periodic Disease)
4. Type II Lattice Corneal Dystrophy
5. Meretoja syndrome

Experts

1. Gettemans, Jan: 2 articles (01/2019 - 12/2016)
2. Larsson, Mårten: 2 articles (01/2019 - 08/2009)
3. Robinson, Robert C: 2 articles (01/2019 - 08/2009)
4. Alafaleq, Munirah: 1 article (09/2021)
5. Borderie, Vincent: 1 article (09/2021)
6. Boutboul, Sandrine: 1 article (09/2021)
7. Knoeri, Juliette: 1 article (09/2021)
8. Grimes, Jonathan M: 1 article (01/2019)
9. Li, Wenfei: 1 article (01/2019)
10. Ren, Weitong: 1 article (01/2019)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Type II Lattice Corneal Dystrophy:
1. GelsolinIBA
2. Amyloid (Amyloid Fibrils)IBA
3. Proteins (Proteins, Gene)FDA Link
4. Amyloidogenic ProteinsIBA
5. Peptides (Polypeptides)IBA
6. Prealbumin (Transthyretin)IBA
7. Apolipoproteins E (ApoE)IBA
8. AntibodiesIBA
9. Microfilament Proteins (Actin Binding Proteins)IBA
10. Amino AcidsFDA Link

Therapies and Procedures

1. Phacoemulsification
2. Penetrating Keratoplasty
3. Contact Lenses
4. Bandages (Bandage)